These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3737050)

  • 1. Uterine contraction pressures with oxytocin induction/augmentation.
    Hauth JC; Hankins GD; Gilstrap LC; Strickland DM; Vance P
    Obstet Gynecol; 1986 Sep; 68(3):305-9. PubMed ID: 3737050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active phase labor arrest: revisiting the 2-hour minimum.
    Rouse DJ; Owen J; Savage KG; Hauth JC
    Obstet Gynecol; 2001 Oct; 98(4):550-4. PubMed ID: 11576566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine contraction pressures achieved in parturients with active phase arrest.
    Hauth JC; Hankins GD; Gilstrap LC
    Obstet Gynecol; 1991 Sep; 78(3 Pt 1):344-7. PubMed ID: 1876362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active-phase labor arrest: oxytocin augmentation for at least 4 hours.
    Rouse DJ; Owen J; Hauth JC
    Obstet Gynecol; 1999 Mar; 93(3):323-8. PubMed ID: 10074971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience with conducting programmed labor].
    Levchenko VG; Rotkina IE; Popov SP
    Akush Ginekol (Mosk); 1991 Apr; (4):33-5. PubMed ID: 1862870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of uterine activity in labour induced with prostaglandin F2alpha or oxytocin and in spontaneous labour. II. Characteristics of uterine activity and their effect on the progress of labour.
    Lindmark G; Nilsson BA
    Acta Obstet Gynecol Scand; 1977; 56(2):87-94. PubMed ID: 857597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expected labor progression after labor augmentation with oxytocin: A retrospective cohort study.
    Zhang L; Troendle J; Branch DW; Hoffman M; Yu J; Zhou L; Duan T; Zhang J
    PLoS One; 2018; 13(10):e0205735. PubMed ID: 30379856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Currently used oxytocin regimen outcome measures at term & postterm. I: Outcome indicators in relation to parity & indication for induction.
    Berhan Y; Dwivedi AD
    Ethiop Med J; 2007 Jul; 45(3):235-42. PubMed ID: 18330323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine activity in dysfunctional labour and target uterine activity to be aimed with oxytocin titration.
    Arulkumaran S; Chua S; Chua TM; Yang M; Piara S; Ratnam SS
    Asia Oceania J Obstet Gynaecol; 1991 Jun; 17(2):101-6. PubMed ID: 1867576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of labour by pharmacological and physiological doses of intravenous oxytocin.
    Toaff ME; Hezroni J; Toaff R
    Br J Obstet Gynaecol; 1978 Feb; 85(2):101-8. PubMed ID: 341964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine electrical activity, oxytocin and labor: translating electrical into mechanical.
    Lavie A; Shinar S; Hiersch L; Ashwal E; Yogev Y; Aviram A
    Arch Gynecol Obstet; 2018 Jun; 297(6):1405-1413. PubMed ID: 29453654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine pressure studies in multigravid patients in spontaneous labour: effect of oxytocin augmentation in delayed first stage.
    Reddi K; Kambaran SR; Philpott RH; Norman RJ
    Br J Obstet Gynaecol; 1988 Aug; 95(8):771-7. PubMed ID: 3166952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracervical prostaglandin E2 gel for cervical ripening and labor induction: what is the appropriate dose?
    Minaretzis D; Tsionu C; Papageorgiou I; Michalas S; Aravantinos D
    Gynecol Obstet Invest; 1993; 35(1):34-7. PubMed ID: 8449431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytotec: an effective drug for the induction of labor].
    Milchev N; Kuzmanov B; Terzhumanov R
    Akush Ginekol (Sofiia); 2003; 42(3):9-11. PubMed ID: 12858483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine contraction pattern as a predictor of the mode of delivery.
    Oppenheimer LW; Bland ES; Dabrowski A; Holmes P; McDonald O; Wen SW
    J Perinatol; 2002 Mar; 22(2):149-53. PubMed ID: 11896521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of oxytocin infusion on uterine activity levels in slow labour.
    Steer PJ; Carter MC; Beard RW
    Br J Obstet Gynaecol; 1985 Nov; 92(11):1120-6. PubMed ID: 4063228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor induction.
    Wing DA; Ortiz-Omphroy G; Paul RH
    Am J Obstet Gynecol; 1997 Sep; 177(3):612-8. PubMed ID: 9322632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approach to oxytocin induction-augmentation of labor. Application of oxytocin physiology during pregnancy.
    Dawood MY
    Adv Exp Med Biol; 1995; 395():585-94. PubMed ID: 8714022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of uterine activity in labour induced with prostaglandin F2alpha or oxytocin and in spontaneous labour. I. Pattern of the uterine contractions.
    Lindmark G; Nilsson BA
    Acta Obstet Gynecol Scand; 1976; 55(5):453-60. PubMed ID: 998176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimum oxytocin dose requirement after cesarean delivery for labor arrest.
    Balki M; Ronayne M; Davies S; Fallah S; Kingdom J; Windrim R; Carvalho JC
    Obstet Gynecol; 2006 Jan; 107(1):45-50. PubMed ID: 16394038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.